This company operates under 1 registered commercial or alternative name, allowing operational flexibility and brand diversification.
๐ขlfb biomedicaments
What do we know about this supplier?
Has participated in 101 contracts for a total amount of EUR 961,950,425
Reports coming soon
Full reports for this country will be available soon. Leave your email and we will notify you when they are ready.
Alternative names
Contracts
This company has participated in 101 public contracts for a total amount of EUR 961,950,425, demonstrating its ability to work with the public sector.
Public contracts represent an important source of income for companies in France and contribute to the country's economic development.
| Description | Entity | Amount | Award date |
|---|---|---|---|
| ๐ซ๐ท Fourniture d'antithrombotiques et antihemorragiques. | CHRU de Tours | EUR 2,706,000 | 2012-05-26 |
| ๐ซ๐ท Fourniture d'albumines humaines teicoplanine valaciclovir. | Hospices civils de Lyon | EUR 1,028,639 | 2012-01-13 |
| ๐ซ๐ท Fourniture de medicaments derives du plasma (Aclotine(r), Alfalastin(r), Hemoleven(r), Ivhebex(r)). | CHRU de Tours | EUR 2,359,550 | 2012-10-31 |
| ๐ซ๐ท Fourniture de specialites pharmaceutiques avec AMM "segments strategiques". | GARPP | EUR 1,950,565 | 2012-07-21 |
| ๐ซ๐ท Fourniture de medicaments derives du sang. | CHR Metz-Thionville | EUR 2,747,698 | 2012-11-28 |
Contracts by method
This supplier has worked with different contracting methods. The distribution of contracts by method shows the diversity of competitiveness with the public sector.
| Method | # Contracts |
|---|---|
| open | 87 |
| direct | 14 |
Main buyers
Main buyers are the entities that have contracted this supplier the most.
| Entidad | No. Contracts | Total amount |
|---|---|---|
| ๐ซ๐ท CHRU de Tours | 15 | EUR 55,899,647 |
| ๐ซ๐ท UNICANCER ACHATS | 13 | EUR 1,774,316 |
| ๐ซ๐ท CHR Metz Thionville | 8 | EUR 36,239,259 |
| ๐ซ๐ท CHU de Nantes | 6 | EUR 91,069,821 |
| ๐ซ๐ท AP-HM | 5 | EUR 52,312,437 |
Additional information
Data sources
This website publishes data from official sources, public databases published by governments. Public access to data is a civil right. The data helps citizen monitor of government spending. The data here is public by law. It does not contain personal data. There is no privacy violation. Privacy policy.

